Enhanced Immunogenicity of Engineered HER2 Antigens Potentiates Antitumor Immune Responses

For cancer vaccines, the selection of optimal tumor-associated antigens (TAAs) that can maximize the immunogenicity of the vaccine without causing unwanted adverse effects is challenging. In this study, we developed two engineered Human epidermal growth factor receptor 2 (HER2) antigens, K965 and K1...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Vaccines (Basel)
Main Authors: Jeon, Insu, Lee, Jeong-Mi, Shin, Kwang-Soo, Kang, Taeseung, Park, Myung Hwan, Seo, Hyungseok, Song, Boyeong, Koh, Choong-Hyun, Choi, Jeongwon, Shin, Young Kee, Kim, Byung-Seok, Kang, Chang-Yuil
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7563373/
https://ncbi.nlm.nih.gov/pubmed/32707803
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines8030403
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados